Clinical Trials Browser

Basal Cell Nevus Syndrome × IPI-926 × Dermatologic × Clear all

NCT06050122 2025-10-14

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Phase 3 Active not recruiting

Basal Cell Nevus Syndrome

NCT02762084 2020-07-23

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Phase 2 Completed

17 enrolled 22 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02828111 2019-01-08

BCC

Phase 2 Completed

36 enrolled 17 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell